Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
02/2010
02/25/2010WO2009110985A3 Amide compounds, compositions and uses thereof
02/25/2010US20100048909 such as (4S,5S) N-cyclopropyl-2-isopropyl-4-propyl-4,5-dihydro-1,3-oxazole-5-carboxamide; cost efficiency, industrial scale
02/25/2010US20100048895 Process for Preparing Heterocyclic Derivatives
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048651 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010CA2733554A1 Mif modulators
02/25/2010CA2730478A1 Prodrugs of methyl hydrogen fumarate
02/24/2010EP2157085A1 Oxazole, derivatives of tetracyclines
02/24/2010EP2155893A2 Novel nitroreductase enzymatic substrates
02/24/2010EP2155892A2 Novel peptidase substrates
02/24/2010EP2155702A1 A process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
02/24/2010EP2155687A1 Diacylglycerol acyltransferase inhibitors
02/24/2010EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs
02/24/2010CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
02/23/2010US7667051 Method of obtaining urethane-protected N-carboxyanhydrides of alpha amino acids
02/18/2010WO2010019830A1 Glucagon antagonists
02/18/2010WO2010019606A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
02/18/2010WO2010018874A1 Amide compound
02/18/2010WO2009132119A3 Substituted oxazolidinones
02/18/2010US20100041896 Macrolide compound with bis-oxazoly
02/18/2010US20100041724 such as anacetrapib; cholesterol ester transfer protein inhibitors (CETP); atherosclerosis
02/18/2010US20100041720 Novel compounds as cannabinoid receptor ligands
02/18/2010US20100041686 4,5-dihydro-oxazol-2yl derivatives
02/18/2010US20100040569 Photo-labile pro-fragrance conjugates
02/18/2010US20100039024 New Heterocyclic bridged biphenyls
02/18/2010DE102008038944A1 New thermoplastic polymer useful e.g. for producing semi-finished or cross-linked molded materials and high performance composite materials for components in automotive, mechanical engineering, electrical engineering and electronics
02/18/2010DE102008038943A1 New crosslinkable acrylate resins, useful e.g. to produce crosslinked semi-finished or molded materials for highly stressed parts in automotive, mechanical-, electrical-engineering and electronics, and as crosslinkers in coating resins
02/18/2010DE102008038941A1 New N-substituted oxazolidine derivatives useful for preparing hydroxyalkylamino and polymeric hydroxyalkylamino derivatives for manufacturing e.g. high-performance composite materials for parts of automotives and electronics
02/18/2010CA2770298A1 Glucagon antagonists
02/18/2010CA2733966A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
02/18/2010CA2733247A1 Heterocyclic amide derivatives as ep4 receptor antagonists
02/17/2010EP2154131A1 G protein-coupled receptor inhibitor and pharmaceutical product
02/16/2010US7662971 enzyme inhibitor for treating sleep disorders
02/16/2010US7662970 reacting an aldehyde and/or a ketone with a secondary amine and a reactant selected from the group consisting of a halohydrin and an epoxide, under reaction conditions sufficient to produce an oxazolidinium compound; antiagglomerant; inhibit forming clathrates during oil and gas production
02/16/2010US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders
02/16/2010US7662771 Drug delivery; controlled/sustained release
02/16/2010CA2478183C Substituted amides
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2385081C Carboxylic acid compound and a medicament comprising it
02/11/2010WO2010017079A1 Oxazole derivatives useful as inhibitors of faah
02/11/2010WO2010015211A1 Synthesis of oxazoline compounds
02/11/2010WO2008010070A3 Novel oxazolidinone derivatives
02/11/2010US20100035944 Compounds and methods for modulating g protein-coupled receptors
02/11/2010CA2732526A1 Oxazole derivatives useful as inhibitors of faah
02/10/2010EP2151438A1 Pharmaceutical containing ppar agonist
02/10/2010EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
02/10/2010EP1833805B1 New 3-phenylpropionic acid derivatives for the treatment of diabetes
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents
02/10/2010CN101646660A Compounds and methods for modulating G protein-coupled receptors
02/10/2010CN101643455A Furazolidone metabolite hapten and antigen as well as preparation method and application thereof
02/09/2010US7659296 2-{1-[4-(3,3-dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-benzooxazole-6-carboxylic acid; 1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-benzooxazole-6-carboxylic acid amide; stimulate bone formation, restore bone quality, acne, alopecia, Alzheimer's disease etc.
02/09/2010US7659295 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
02/09/2010US7659267 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/04/2010WO2010014566A2 Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
02/04/2010WO2010012794A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
02/04/2010WO2010012775A1 Process for the synthesis of ezetimibe and intermediates useful therefor
02/04/2010WO2010012107A1 Selective glycosidase inhibitors and uses thereof
02/04/2010WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
02/04/2010US20100029689 Phosphodiesterase 4 inhibitors
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029589 4,5-dihydro-oxazol-2yl derivatives
02/04/2010CA2732336A1 Selective glycosidase inhibitors and uses thereof
02/04/2010CA2732017A1 Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
02/04/2010CA2731924A1 Process for the synthesis of ezetimibe and intermediates useful therefor
02/04/2010CA2731198A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
02/04/2010CA2730711A1 Asymmetric process for making substituted 2-amino-thiazolones
02/03/2010EP2149547A1 Process for the synthesis of ezetimibe and intermediates useful therefor
02/03/2010EP2148858A1 Inhibitors of iap
02/03/2010CN101638392A Novel preparation method of netaglinide oxazolone
02/02/2010US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
02/02/2010US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
02/02/2010US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
02/02/2010US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases
02/02/2010US7655600 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating insects, arachnids and nematodes
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/28/2010WO2010010435A2 Fused oxazole and thiazole derivatives as trpms modulators
01/28/2010WO2010010014A1 4,5-dihydro-oxazol-2-yl derivatives
01/28/2010US20100022773 Apoptosis promoters
01/28/2010US20100022772 Process for the synthesis of biaryl oxazolidnones
01/28/2010CA2728480A1 4,5-dihydro-oxazol-2-yl derivatives
01/27/2010CN101636390A Napadisylate salt of a muscarinic M3 antagonist
01/26/2010US7652049 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis; antiinflammatory agent; synergistic mixture with other active ingredients
01/26/2010US7652045 Activator of peroxisome proliferator-activated receptor δ
01/26/2010US7652044 P-38 inhibitors
01/26/2010US7652036 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010CA2430579C Isoindolin-1-one glucokinase activators
01/21/2010WO2010009405A2 Targeted nitroxide agents
01/21/2010WO2010008522A2 Nucleophilic fluorination of aromatic compounds
01/21/2010WO2009046841A8 Piperidine and piperazine derivatives for treating tumours
01/21/2010US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties
01/21/2010US20100016304 Glucokinase activator
01/20/2010EP2144505A1 Insecticidal derivatives of substituted benzylamines
01/20/2010EP1633730B1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
01/20/2010EP1568701B1 Transition metal complex having diphosphine complex as ligand
01/20/2010EP1555257B1 Process for producing aromatic nitrile compound
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 210